JPWO2022223750A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022223750A5
JPWO2022223750A5 JP2023564563A JP2023564563A JPWO2022223750A5 JP WO2022223750 A5 JPWO2022223750 A5 JP WO2022223750A5 JP 2023564563 A JP2023564563 A JP 2023564563A JP 2023564563 A JP2023564563 A JP 2023564563A JP WO2022223750 A5 JPWO2022223750 A5 JP WO2022223750A5
Authority
JP
Japan
Prior art keywords
azaspiro
heptan
methanone
triazol
cyclopropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023564563A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024521618A (ja
JP2024521618A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/060644 external-priority patent/WO2022223750A1/en
Publication of JP2024521618A publication Critical patent/JP2024521618A/ja
Publication of JPWO2022223750A5 publication Critical patent/JPWO2022223750A5/ja
Publication of JP2024521618A5 publication Critical patent/JP2024521618A5/ja
Pending legal-status Critical Current

Links

JP2023564563A 2021-04-23 2022-04-22 複素環式化合物 Pending JP2024521618A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP21170090.1 2021-04-23
EP21170090 2021-04-23
CNPCT/CN2022/083125 2022-03-25
CN2022083125 2022-03-25
PCT/EP2022/060644 WO2022223750A1 (en) 2021-04-23 2022-04-22 Heterocyclic compounds

Publications (3)

Publication Number Publication Date
JP2024521618A JP2024521618A (ja) 2024-06-04
JPWO2022223750A5 true JPWO2022223750A5 (https=) 2025-04-22
JP2024521618A5 JP2024521618A5 (https=) 2025-04-22

Family

ID=81750728

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023564563A Pending JP2024521618A (ja) 2021-04-23 2022-04-22 複素環式化合物

Country Status (16)

Country Link
US (1) US20240199587A1 (https=)
EP (1) EP4326714A1 (https=)
JP (1) JP2024521618A (https=)
KR (1) KR20240000574A (https=)
CN (1) CN117295726A (https=)
AR (1) AR125401A1 (https=)
AU (1) AU2022260537A1 (https=)
CA (1) CA3215260A1 (https=)
CL (1) CL2023003154A1 (https=)
CO (1) CO2023014721A2 (https=)
CR (1) CR20230496A (https=)
IL (1) IL306126A (https=)
MX (1) MX2023012477A (https=)
PE (1) PE20240239A1 (https=)
TW (1) TW202309010A (https=)
WO (1) WO2022223750A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2986417T3 (es) 2018-08-13 2024-11-11 Hoffmann La Roche Nuevos compuestos heterocíclicos como inhibidores de la monoacilglicerol lipasa
ES2955037T3 (es) 2018-11-22 2023-11-28 Hoffmann La Roche Nuevos compuestos heterocíclicos
WO2023130043A1 (en) * 2021-12-29 2023-07-06 Psy Therapeutics, Inc. Monoacylglycerol lipase inhibitors and use thereof for the treatment of anxiety
WO2023130050A1 (en) * 2021-12-29 2023-07-06 Psy Therapeutics, Inc. Monoacylglycerol lipase inhibitors and use thereof for the treatment and management of pain
CA3242372A1 (en) * 2021-12-29 2023-07-06 Psy Therapeutics, Inc. Inhibiting monoacylglycerol lipase (magl)
WO2023144160A1 (en) * 2022-01-25 2023-08-03 F. Hoffmann-La Roche Ag New heterocyclic compounds
JP2025525350A (ja) * 2022-06-24 2025-08-05 エフ. ホフマン-ラ ロシュ アーゲー Magl阻害剤としての新規複素環-カルボニル-環式化合物
CA3261681A1 (en) 2022-08-05 2024-02-08 Kumquat Biosciences Inc. HETEROCYCLIC COMPOUNDS AND THEIR USES
WO2024215863A2 (en) * 2023-04-13 2024-10-17 Psy Therapeutics, Inc. Inhibiting monoacylglycerol lipase (magl)
WO2025010392A2 (en) * 2023-07-06 2025-01-09 Psy Therapeutics, Inc. Monoacylglycerol lipase inhibitors and use thereof for the treatment of neurological disorders
WO2025010394A2 (en) * 2023-07-06 2025-01-09 Psy Therapeutics, Inc. Monoacylglycerol lipase inhibitors and use thereof for the treatment and management of inflammatory conditions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20171057A1 (es) * 2014-10-08 2017-07-21 Hoffmann La Roche Derivados espirodiamina como inhibidores de la aldosterona sintasa
UA125171C2 (uk) * 2015-07-02 2022-01-26 Янссен Саєнсиз Айрленд Юсі Антибактеріальні сполуки
KR102765806B1 (ko) * 2017-09-05 2025-02-10 블랙손 테라퓨틱스, 인크. 바소프레신 수용체 길항제 및 그와 관련된 제품 및 방법
JP2021516229A (ja) * 2018-02-28 2021-07-01 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 低親和性ポリ(ad−リボース)ポリメラーゼ1依存性細胞毒性剤
WO2019209962A1 (en) * 2018-04-25 2019-10-31 Yumanity Therapeutics, Inc. Compounds and uses thereof
ES2955037T3 (es) * 2018-11-22 2023-11-28 Hoffmann La Roche Nuevos compuestos heterocíclicos
CN111793064B (zh) * 2019-04-02 2023-06-23 上海美悦生物科技发展有限公司 一种作为irak抑制剂的化合物及其制备方法和用途
MX2023003240A (es) * 2020-09-22 2023-06-16 Janssen Pharmaceutica Nv Moduladores de monoacilglicerol lipasa de ciclobutilamida.

Similar Documents

Publication Publication Date Title
IL306126A (en) Heterocyclic compounds
JP2021502356A5 (https=)
IL299180A (en) 2-OXOIMIDAZOLIDINE-4-CARBOXAMIDES AS NAV1.8 INHIBITORS
JP2019504821A5 (https=)
JP2017502049A5 (https=)
JP2019519484A5 (https=)
JP2011503166A5 (https=)
JP2017500364A5 (https=)
JP2013523884A5 (https=)
HRP20201746T1 (hr) Aromatski derivati sulfonamida
JP2010510319A5 (https=)
JP2015522002A5 (https=)
JP2019530695A5 (https=)
JP2019523233A5 (https=)
JP2014518214A5 (https=)
JP2019504854A5 (https=)
RU2016124178A (ru) Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
RU2015152576A (ru) Производные индолин-2-она или пирролопиридин/пиримидин-2-она
CA2642922A1 (en) Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
RU2013155456A (ru) Соединения пирролидинилмочевины и пирролидинилтиомочевины как ингибиторы киназы trka
HRP20160539T1 (hr) Antagonisti trpv4
JP2013508404A5 (https=)
JPWO2022223750A5 (https=)
RU2012146246A (ru) Антибактериальные производные изохинолин-3-илмочевины
JP2016523976A5 (https=)